hepatitis a virus gbm strain inactivated
PolandDrugs containing this active substance
-
The vaccine is used to immunize adults and adolescents over 16 years of age against hepatitis A virus (HAV).
Form: solution for injection in ampoule-syringe
Active substance Dosage hepatitis a virus gbm strain inactivated 160 antigenic units ATC: J07BC02
Manufacturer: Sanofi Winthrop Industry Sanofi Winthrop Industry Sanofi-Aventis Ltd.